Keywords: merck, co, rizatriptan, approved, holland, oral, serotonin

Merck & Co's Rizatriptan Approved In Holland

Article | 25 February 1998

Print This

Merck & Co's oral serotonin 5-HT1B/1D agonist for migraine, Maxalt(rizatriptan), has been approved in Holland, its second market ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in